核VAV1增加了胰腺癌细胞中的GLI1依赖转录
Brooke R Tader1, Luciana L Almada2, Murat Toruner2
1Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA; Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, Minnesota, USA.
The Journal of biological chemistry
|November 28, 2025
概括
核VAV1通过增强GLI1转录活性和BCL2表达来促进胰腺癌. 这项研究揭示了一种新的致癌机制,涉及核VAV1在胰腺管道腺癌的发展.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 已知VAV1 (瓜核酸交换因子) 的致癌作用,主要与其细胞质活性有关.
- 核VAV1对癌症的发展,特别是胰腺管道腺癌 (PDAC) 的贡献尚不清楚.
研究的目的:
- 研究核VAV1在PDAC中驱动瘤基因表达的新奇机制.
- 阐明核VAV1在调节GLI转录活性和基因表达中的作用.
主要方法:
- 利用PDAC细胞模型来比较野生型VAV1和缺乏核定位信号 (NLS) 的突变体.
- 评估了VAV1核定位,GLI转录活性,蛋白相互作用 (VAV1,GLI1,Importin b1,PCAF) 和基因表达 (BCL2).
- 进行了VAV1淘汰和染色体免疫沉试验,以分析BCL2促进体调节.
主要成果:
- 核VAV1增加了PDAC细胞中的GLI转录活性,而不会改变GLI因子表达.
- VAV1与GLI1相互作用,并且对于GLI目标基因的表达是必需的,包括BCL2.
- VAV1与BCL2促进体结合,并促进GLI1和PCAF联合激活体的结合,维持BCL2表达和促进体活性.
结论:
- 核VAV1在PDAC中调节GLI1转录活性方面发挥着至关重要的作用.
- VAV1的核功能代表了一种新的机制,有助于胰腺癌的瘤发生.
- 针对核VAV1可能为PDAC提供新的治疗策略.
相关概念视频
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Induced Pluripotent Stem Cells
5.3K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.3K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Cancer-Critical Genes I: Proto-oncogenes
11.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.1K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Cancer Cell Migration through Invadopodia
3.2K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.2K


